Tech Company Financing Transactions
Transgenomic Funding Round
Transgenomic closed a $3 million venture capital round on 7/17/2015. Investors included private investors.
Transaction Overview
Company Name
Announced On
7/17/2015
Transaction Type
Venture Equity
Amount
$3,039,760
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
12325 Emmet St.
Omaha, NE 68164
USA
Omaha, NE 68164
USA
Phone
Website
Email Address
Overview
Transgenomic, Inc. (OTCBB: TBIO) is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Kinnon
Chief Financial Officer
Leon Richards
Vice President
Steve Miller
VP - Human Resources
Joanne Lewis
Browse more venture capital transactions:
Prev: 7/17/2015: Sportlogiq venture capital transaction
Next: 7/17/2015: Celmatix venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs